| Форма представления | Статьи в зарубежных журналах и сборниках |
| Год публикации | 2022 |
| Язык | английский |
|
Ключарова Алия Рафаиловна, автор
Мартынова Екатерина Владимировна, автор
Ризванов Альберт Анатольевич, автор
Хайбуллина Светлана Францевна, автор
|
| Библиографическое описание на языке оригинала |
EXACERBATION OF CHRONIC SPONTANEOUS URTICARIA SYMPTOMS IN COVID-19 PATIENTS, CASE REPORT
Klyucharova A., Martynova E., Rizvanov A., Khaiboullina S.
BioNanoScience. 2022. Т. 12. № 4. С. 1482-1488 |
| Аннотация |
BioNanoScience |
| Ключевые слова |
URTICARIA ? COVID-19 ? Chronic spontaneous urticaria |
| Название журнала |
BioNanoScience
|
| Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку |
https://repository.kpfu.ru/?p_id=283447 |
| Файлы ресурса | |
|
|
Полная запись метаданных  |
| Поле DC |
Значение |
Язык |
| dc.contributor.author |
Ключарова Алия Рафаиловна |
ru_RU |
| dc.contributor.author |
Мартынова Екатерина Владимировна |
ru_RU |
| dc.contributor.author |
Ризванов Альберт Анатольевич |
ru_RU |
| dc.contributor.author |
Хайбуллина Светлана Францевна |
ru_RU |
| dc.date.accessioned |
2022-01-01T00:00:00Z |
ru_RU |
| dc.date.available |
2022-01-01T00:00:00Z |
ru_RU |
| dc.date.issued |
2022 |
ru_RU |
| dc.identifier.citation |
EXACERBATION OF CHRONIC SPONTANEOUS URTICARIA SYMPTOMS IN COVID-19 PATIENTS, CASE REPORT
Klyucharova A., Martynova E., Rizvanov A., Khaiboullina S.
BioNanoScience. 2022. Т. 12. № 4. С. 1482-1488 |
ru_RU |
| dc.identifier.uri |
https://repository.kpfu.ru/?p_id=283447 |
ru_RU |
| dc.description.abstract |
BioNanoScience |
ru_RU |
| dc.description.abstract |
Chronic spontaneous urticaria (CSU) is characterized by wheals lasting more than 6 weeks and can be accompanied by
angioedema. Treatment of the disease varies depending on the severity and includes frst-line therapeutics such as nonsedative antihistamines. Second- and third-line treatments are used in severe and uncontrolled form of CSU. Environmental
exposure and infections could trigger worsening symptoms. The goal of this study is to assess the efect of SARS-CoV-2
infection on CSU symptoms and the efcacy of the second- and third-line therapeutics for CSU management in COVID-19
patients. Our fndings show that SARS-CoV-2 infection exacerbates CSU symptoms. Worsening of disease was indicated by
decreased Urticaria Control Test (UCT) and increased Urticaria Activity Score (UAS). Treatment management was modifed by switching to second- and third-line therapeutics; however, therapeutic control was achieved only in one patient. Our
data demonstrates that SARS-CoV-2 infection contributes to the severity of CSU. Symptoms of CSU are more challenging
to manage and require changes in treatment protocol, including second- and third-line therapeutics. We believe that severe
infammation triggered by SARS-CoV-2 infection contributes to the worsening of CSU symptoms. |
ru_RU |
| dc.language.iso |
ru |
ru_RU |
| dc.subject |
|
ru_RU |
| dc.title |
EXACERBATION OF CHRONIC SPONTANEOUS URTICARIA SYMPTOMS IN COVID-19 PATIENTS, CASE REPORT |
ru_RU |
| dc.type |
Статьи в зарубежных журналах и сборниках |
ru_RU |
|
EN 
中文 
ES 
Карта сайта
